Healthcare and Pharmaceuticals industry

Global Next Generation Sequencing Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Report Description
Next Generation Sequencing (NGS) is a high-throughput DNA sequencing technology that separates billions or millions of DNA strands and sequence in parallel, yielding more output and reducing the need for fragment-cloning methods (Sanger sequencing of genomes). However, read lengths for NGS are shorter than Sanger due to the signal to noise ratio, which increases with read length. NGS allows simultaneous screening of mutations in large number of genes. For example, a patient with symptoms of Leigh syndrome performed exome sequencing to find candidate gene variants. Furthermore, it is used for analysis and for interpreting sequenced data, analyzing specific gene associated with the patient's clinical condition.
Market Dynamics
Major factors driving growth of the next generation sequencing market are early detection of cancer and infectious diseases and increasing partnership among academic and industry partnerships for research and development. For academic institutions, these collaborations help in commercialization of their discoveries from basic research to medical products. For instance, in March, 2018, Cofactor Genomics, a U.S.-based developer of Cofactor Paragon (RNA analysis tool) signed agreement with National Cancer Institute, and other three other pharma and academic institutes to show clinical ability of its product.
Increasing prevalence of cancer and infectious diseases and ability of NGS platforms to detect cancers and infectious diseases are expected to drive growth of the next generation sequencing market during the forecast period. The use of NSG for study of cancer cells mutations is increasing and the implementation of this technology has considerably aided in early diagnosis of diseases. In the U.S., over 1.69 million new cancer cases were detected in 2016; whereas the global incidence of cancer was around 14 million new cases in 2012 and an annual 19.3 million cases are estimated by 2025. However, interpretation of complex data, lack of skilled professionals, and issues related to security of NGS data are expected to limit growth of the market.
Key features of the study:
• This report provides in-depth analysis of next generation sequencing market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 - 2025), considering 2016 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global next generation sequencing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., BioMerieux S.A., F. Hoffmann-La Roche Ltd, Qiagen N.V., Illumina, Inc., Oxford Nanopore Technologies, and Beijing Genomics Co. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global next generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the next generation sequencing market
Detailed Segmentation:
• Global Next Generation Sequencing Market, By Technology:
o Whole Genome Sequencing
o Whole Exome Sequencing
o RNA Sequencing
o Targeted Re-sequencing
o Others
• Global Next Generation Sequencing Market, By Application:
o Drug Discovery
o Personalized Medicine and Genetic Screening
o Disease Diagnosis
o Agriculture and Animal Research
o Others
• Global Next Generation Sequencing Market, By End User:
o Hospital
o Research Centers
o Pharma and Biotech Firms
o Others
• Global Next Generation Sequencing Market, By Region:
o North America
 By Technology:
 Whole Genome Sequencing
 Whole Exome Sequencing
 RNA Sequencing
 Targeted Re-sequencing
 Others
 By Application:
 Drug Discovery
 Personalized Medicine and Genetic Screening
 Disease Diagnosis
 Agriculture and Animal Research
 Others
 By End User:
 Hospital
 Research Centers
 Pharma and Biotech Firms
 Others
 By Country:
 U.S.
 Canada
o Latin America
 By Technology:
 Whole Genome Sequencing
 Whole Exome Sequencing
 RNA Sequencing
 Targeted Re-sequencing
 Others
 By Application:
 Drug Discovery
 Personalized Medicine and Genetic Screening
 Disease Diagnosis
 Agriculture and Animal Research
 Others
 By End User:
 Hospital
 Research Centers
 Pharma and Biotech Firms
 Others
 By Country:
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 By Technology:
 Whole Genome Sequencing
 Whole Exome Sequencing
 RNA Sequencing
 Targeted Re-sequencing
 Others
 By Application:
 Drug Discovery
 Personalized Medicine and Genetic Screening
 Disease Diagnosis
 Agriculture and Animal Research
 Others
 By End User:
 Hospital
 Research Centers
 Pharma and Biotech Firms
 Others
 By Country:
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 By Technology:
 Whole Genome Sequencing
 Whole Exome Sequencing
 RNA Sequencing
 Targeted Re-sequencing
 Others
 By Application:
 Drug Discovery
 Personalized Medicine and Genetic Screening
 Disease Diagnosis
 Agriculture and Animal Research
 Others
 By End User:
 Hospital
 Research Centers
 Pharma and Biotech Firms
 Others
 By Country:
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 By Technology:
 Whole Genome Sequencing
 Whole Exome Sequencing
 RNA Sequencing
 Targeted Re-sequencing
 Others
 By Application:
 Drug Discovery
 Personalized Medicine and Genetic Screening
 Disease Diagnosis
 Agriculture and Animal Research
 Others
 By End User:
 Hospital
 Research Centers
 Pharma and Biotech Firms
 Others
 By Country:
 GCC
 Israel
 Rest of Middle East
o Africa
 By Technology:
 Whole Genome Sequencing
 Whole Exome Sequencing
 RNA Sequencing
 Targeted Re-sequencing
 Others
 By Application:
 Drug Discovery
 Personalized Medicine and Genetic Screening
 Disease Diagnosis
 Agriculture and Animal Research
 Others
 By End User:
 Hospital
 Research Centers
 Pharma and Biotech Firms
 Others
 By Country:
 South Africa
 Central Africa
 North Africa
• Company Profiles
o Thermo Fisher Scientific Inc.*
 Company Overview
 Product Portfolio
 Key Highlights
 Financial Overview
 Market Strategies
o Agilent Technologies, Inc.
o BioMerieux S.A.
o F. Hoffmann-La Roche Ltd
o Qiagen N.V.
o Illumina, Inc.
o Oxford Nanopore Technologies
o Beijing Genomics Co. Ltd.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Technology
? Market Snippet, By Application
? Market Snippet, By End User
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o PEST Analysis
o PORTER's Five Forces Model
o Epidemiology
o Market Trends
o Alliances
4. Global Next Generation Sequencing Market, By Technology, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Whole Genome Sequencing
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Whole Exome Sequencing
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o RNA Sequencing
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Targeted Re-sequencing
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
5. Global Next Generation Sequencing Market, By Application, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Drug Discovery
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Personalized Medicine and Genetic Screening
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Disease Diagnosis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Agriculture and Animal Research
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
6. Global Next Generation Sequencing Market, By End User, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Hospital
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Research Centers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Pharma and Biotech Firms
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
7. Global Next Generation Sequencing Market, By Region, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, For Region, 2016 - 2025
? Regional Trends
o North America
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Europe
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Product, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? South Africa
? Central Africa
? North Africa
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Thermo Fisher Scientific Inc.*
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Agilent Technologies, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? BioMerieux S.A.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? F. Hoffmann-La Roche Ltd
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Qiagen N.V.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Illumina, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Oxford Nanopore Technologies
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Beijing Genomics Co. Ltd.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 50 market data tables and 25 figures on "Global Next Generation Sequencing Market - Global forecast to 2025".
 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.